News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RBCC Partner n3D Commercializes New 3D Bioprinting Technology


1/13/2014 7:48:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp.’s (OTCBB: RBCC) joint venture partner, Nano3D Biosciences (n3D), has developed the first commercially available 3D bioprinting system designed for high throughput and high-content drug screening, and the global market potential for the device points to very bright future for the company.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES